Log in
Enquire now
Celyad

Celyad

Celyad is a biotechnology company developing immunotherapies for treating cancer.

OverviewStructured DataIssuesContributors

Contents

c3bs.com
celyad.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
‌
CAR T-Cell therapy
Stem cell
Stem cell
Regenerative medicine
Regenerative medicine
Healthcare
Healthcare
Biopharmaceutical
Biopharmaceutical
Medicine
Medicine
Therapeutics
Therapeutics
...
Location
New York
New York
Mont-Saint-Guibert
Mont-Saint-Guibert
0
Belgium
Belgium
United States
United States
New York City
New York City
0
AngelList URL
angel.co/cardio3-biosciences
Pitchbook URL
pitchbook.com/profiles.../56851-48
Legal Name
Celyad Oncology SA
Date Incorporated
2007
Number of Employees (Ranges)
51 – 200
Email Address
www.celyad.com
info@celyad.com0
Phone Number
+185799069000
+32103941000
Full Address
60 Broad Street Suite 3502 New York, NY 10004 USA0
Axis Business Park Rue Edouard Belin 2 1435 Mont-Saint-Guibert Belgium0
CIK Number
1,637,8900
Place of Incorporation
Belgium
Belgium
0
Investors
S.R.I.W.
S.R.I.W.
Founded Date
2007
Fax Number
+32(0) 10 39 41 410
Exchange
Nasdaq
Nasdaq
Board of Directors
‌
Chris Buyse
0
‌
Hilde Windels
0
‌
Dominic Piscitelli
0
Patents Assigned (Count)
1
Wellfound ID
cardio3-biosciences
Country
Belgium
Belgium

Other attributes

Company Operating Status
Active
Contact Page URL
celyad.com/contact-us/
Previous Name
CELYAD S.A.0
CARDIO3 BIOSCIENCES S.A.0
Public/Private
Private0
SIC Code
2,8340
Ticker Symbol
CYAD

Introduction to Celyad.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Celyad Doses First mCRC Patient in the Phase 1 alloSHRINK Trial Evaluating Non-Gene Edited Allogeneic CAR-T Candidate, CYAD-101

Celyad SA

https://www.globenewswire.com/news-release/2018/11/30/1659763/0/en/Celyad-Doses-First-mCRC-Patient-in-the-Phase-1-alloSHRINK-Trial-Evaluating-Non-Gene-Edited-Allogeneic-CAR-T-Candidate-CYAD-101.html

Web

Celyad in New Collaboration to Develop Allogeneic CAR T-cell Therapies

Alice Melao

https://immuno-oncologynews.com/2018/10/19/celyad-in-new-collaboration-to-develop-allogeneic-car-t-cell-therapies/

Web

Celyad Teaser

https://www.youtube.com/watch?v=sGaT-lG0_FU

November 24, 2016

Reportage TVCom: Celyad la seule entreprise wallonne cotée à Wall Street

https://www.youtube.com/watch?v=q4QVwdqD0rs

May 10, 2017

Shareholders Meeting, November 22nd 2016

https://www.youtube.com/watch?v=MSw5GyKRYTo

November 24, 2016

References

Find more companies like Celyad

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.